Capsule
endoscopy is a painless, minimally invasive technique used for detection of
digestive disorders. It is a wireless, small, pill-sized camera that can be
swallowed & allows direct visualization of the gastrointestinal mucosa.
Another components are batteries, transmitter, and a light source. Capsule
endoscopy is performed to detect Crohn’s disease, obscure gastrointestinal
bleeding, adverse reactions to nonsteroidal anti-inflammatory drugs (NSAID),
celiac disease, tumors in the small intestine, and various other conditions
that inflict the digestive system. It is a method to record the images of
digestive tract which is further used in diagnosis of the intestinal diseases.
The procedure helps to examine the lining of gastrointestinal tract which comprises
three portions of the small intestine: ileum, duodenum, and jejunum.
According
to study, “Global Capsule Endoscopy Market
Information by Component (Capsule Endoscope, Capsule Endoscopy Data Recorders,
Capsule Endoscopy Workstations), by Endoscope Type (Cystoscopies,
Neuro-Endoscopes), by Product (Colon Capsule, Esophageal Capsule, Small Bowel
Capsule), by Application (Crohn's Disease, Intestine Disease, Obscure
Gastrointestinal Bleeding), by End-user (Hospitals, Clinics), and Region -
Forecast till 2023” the key companies operating in
the global capsule endoscopy market are Capsovision, Medtronic Plc., Chongqing
Jinshan Science and Technology, Given Imaging, Fujifilm Holding Corp.,
Check-Cap Ltd., RF System Lab, Olympus Corporation, IntroMedic Co.
Based
on component type, capsule endoscopy market is segmented into capsule
endoscope, capsule endoscopy workstations and capsule endoscopy data recorders.
Capsule endoscope segment holds major share in market owing to increase in
utilization of different types of capsule endoscopes. Based on endoscope type,
market is segmented into capsule neuro-endoscopes and capsule cystoscopies.
Based on product type, market is segmented into small bowel capsule, colon
capsule and esophageal capsule. Based on application, market is segmented into
Obscure gastrointestinal bleeding (OGIB), small intestine tumor and Crohn's
disease. In addition, based on end-user, market is segmented into clinics,
hospitals and others.
The
capsule endoscopy market is driven by rise in prevalence of small intestinal
disorders, followed by increase in geriatric population, rise in a shift of
patients towards the advanced diagnostics, increase in patient awareness
levels, rise in disposable income, huge investments in research &
development (R&D) by key industry players and increase in importance of
minimal invasive in primary diagnosis. However, lack of skilled physicians,
inadequate reimbursement policies and rise in risks & complications of
capsule endoscopy may impact the market. Moreover, surge in technological
advancements in capsule endoscopy is a key opportunity for market.
Based
on geography, the North-American region holds major share in capsule endoscopy
market owing to well-developed technology, presence of huge patients suffering
from intestinal diseases, rise in establishment of endoscopic training centers
and high healthcare expenditure in the region. The European and Asian-Pacific
region is projected to witness lucrative growth rate due to growth in Crohn’s
disease & ulcerative colitis, increase in availability of low cost
procedures, rise in number of gastrointestinal cases & colon cancer
patients and vast population base over the forecast period. It is predicted
that the market will be reached at rapid pace caused by rapid development and
launch of novel bio-similars & drugs for the treatment of diseases during
the forecast period.
To know more, click on
the link below:-
Related Reports:-
Contact Us:-
Ken
Research
Ankur
Gupta, Head Marketing & Communications
+91-9015378249
No comments:
Post a Comment